AG˹ٷ

STOCK TITAN

[Form 4] Sabra Healthcare REIT, Inc. Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

Catherine Cusack, a director of Sabra Health Care REIT, Inc. (SBRA), was credited with 877 additional common stock units on 08/29/2025 as dividend equivalent payments under the Issuer's 2009 Performance Incentive Plan at no cash cost. Following the transaction she beneficially owns 71,276 shares or stock units in total, which includes 6,922 unvested stock units and 49,854 vested units with deferred payment. Each stock unit equals the right to receive one share of common stock and the dividend-equivalent units will vest and pay out on the same schedule as the original awards.

Catherine Cusack, membro del consiglio di amministrazione di Sabra Health Care REIT, Inc. (SBRA), ha ricevuto 877 unità aggiuntive di azioni ordinarie il 29/08/2025 come pagamento equivalente a dividendi nell'ambito del Performance Incentive Plan 2009 dell'Emittente, senza alcun costo in contanti. Dopo la registrazione della transazione possiede beneficiariamente in totale 71.276 azioni o unità azionarie, di cui 6.922 unità non ancora maturate e 49.854 unità già maturate con pagamento differito. Ogni unità azionaria corrisponde al diritto di ricevere una azione ordinaria e le unità equivalenti ai dividendi matureranno e verranno liquidate secondo lo stesso programma dei premi originari.

Catherine Cusack, directora de Sabra Health Care REIT, Inc. (SBRA), recibió 877 unidades adicionales de acciones ordinarias el 29/08/2025 como pagos equivalentes a dividendos bajo el Plan de Incentivos por Desempeño 2009 del emisor, sin costo en efectivo. Tras la operación posee beneficiariamente un total de 71.276 acciones o unidades de acciones, que incluyen 6.922 unidades no adquiridas y 49.854 unidades adquiridas con pago diferido. Cada unidad de acciones equivale al derecho a recibir una acción ordinaria y las unidades equivalentes a dividendos devengarán y se pagarán según el mismo calendario de los premios originales.

Sabra Health Care REIT, Inc.(SBRA) 이사� 일원� Catherine Cusack은 발행회사� 2009 성과 인센티브 플랜� 따라 2025� 8� 29� 배당액에 상응하는 지급으� 현금 비용 없이 추가 보통� 단위 877주를 부여받았습니다. 해당 거래 이후 그녀� � 71,276주의 보유 지�(주식 또는 주식 단위)� 실질적으� 보유하고 있으�, � � 6,922주는 아직 베스팅되지 않은 단위이고 49,854주는 지급이 연기� 베스팅된 단위입니�. � 주식 단위� 보통� 1주를 수령� 권리� 의미하며, 배당� 상응하는 단위� 원래 부여된 보상� 동일� 일정� 따라 베스트되� 지급됩니다.

Catherine Cusack, administratrice de Sabra Health Care REIT, Inc. (SBRA), s'est vu attribuer 877 unités supplémentaires d'actions ordinaires le 29/08/2025 en tant que paiements équivalents aux dividendes dans le cadre du Performance Incentive Plan 2009 de l'émetteur, sans coût en numéraire. À la suite de la transaction, elle détient au total, à titre bénéficiaire, 71 276 actions ou unités d'actions, comprenant 6 922 unités non acquises et 49 854 unités acquises avec paiement différé. Chaque unité d'action équivaut au droit de recevoir une action ordinaire et les unités équivalentes aux dividendes acquerront leurs droits et seront versées selon le même calendrier que les attributions initiales.

Catherine Cusack, Direktorin von Sabra Health Care REIT, Inc. (SBRA), erhielt am 29.08.2025 als dividendenäquivalente Zahlung im Rahmen des Performance Incentive Plan 2009 des Emittenten 877 zusätzliche Stammaktieneinheiten ohne Baraufwand. Nach der Transaktion besitzt sie wirtschaftlich insgesamt 71.276 Aktien oder Aktieneinheiten, darunter 6.922 nicht unverfallbare (unvested) Einheiten und 49.854 unverfallbare, mit aufgeschobener Auszahlung versehene Einheiten. Jede Aktieneinheit entspricht dem Recht auf den Erhalt einer Stammaktie, und die dividendenäquivalenten Einheiten werden nach dem gleichen Zeitplan wie die ursprünglichen Zuwendungen unverfallbar und ausgezahlt.

Positive
  • Director alignment: Reporting person received 877 dividend-equivalent stock units, increasing insider stake and aligning interests with shareholders
  • Transparency: Filing clearly discloses breakdown of 6,922 unvested units and 49,854 vested but deferred units, clarifying timing and nature of holdings
Negative
  • None.

Insights

TL;DR: Director received dividend-equivalent stock units, modestly increasing her beneficial stake; transaction is routine director compensation.

This Form 4 reports a non-cash acquisition of 877 stock units as dividend equivalents under the company's 2009 Performance Incentive Plan. Such payments are common mechanisms to preserve economic equivalence for deferred equity awards. The report states total beneficial ownership at 71,276 units, with 6,922 unvested and 49,854 vested but deferred, clarifying the mix of immediate and contingent ownership. There is no cash purchase or option exercise disclosed.

TL;DR: Disclosure shows routine equity compensation activity with no immediate cash flow or exercised options; immaterial to valuation alone.

The filing documents a non-derivative acquisition coded as "A" for 877 units credited at a price of $0, consistent with dividend-equivalent accruals on outstanding performance-based units. The explanation ties these units to prior awards and confirms identical vesting/payment terms. For investors evaluating share count or insider alignment, this is a standard administrative increase in insider holdings rather than a market-moving transaction.

Catherine Cusack, membro del consiglio di amministrazione di Sabra Health Care REIT, Inc. (SBRA), ha ricevuto 877 unità aggiuntive di azioni ordinarie il 29/08/2025 come pagamento equivalente a dividendi nell'ambito del Performance Incentive Plan 2009 dell'Emittente, senza alcun costo in contanti. Dopo la registrazione della transazione possiede beneficiariamente in totale 71.276 azioni o unità azionarie, di cui 6.922 unità non ancora maturate e 49.854 unità già maturate con pagamento differito. Ogni unità azionaria corrisponde al diritto di ricevere una azione ordinaria e le unità equivalenti ai dividendi matureranno e verranno liquidate secondo lo stesso programma dei premi originari.

Catherine Cusack, directora de Sabra Health Care REIT, Inc. (SBRA), recibió 877 unidades adicionales de acciones ordinarias el 29/08/2025 como pagos equivalentes a dividendos bajo el Plan de Incentivos por Desempeño 2009 del emisor, sin costo en efectivo. Tras la operación posee beneficiariamente un total de 71.276 acciones o unidades de acciones, que incluyen 6.922 unidades no adquiridas y 49.854 unidades adquiridas con pago diferido. Cada unidad de acciones equivale al derecho a recibir una acción ordinaria y las unidades equivalentes a dividendos devengarán y se pagarán según el mismo calendario de los premios originales.

Sabra Health Care REIT, Inc.(SBRA) 이사� 일원� Catherine Cusack은 발행회사� 2009 성과 인센티브 플랜� 따라 2025� 8� 29� 배당액에 상응하는 지급으� 현금 비용 없이 추가 보통� 단위 877주를 부여받았습니다. 해당 거래 이후 그녀� � 71,276주의 보유 지�(주식 또는 주식 단위)� 실질적으� 보유하고 있으�, � � 6,922주는 아직 베스팅되지 않은 단위이고 49,854주는 지급이 연기� 베스팅된 단위입니�. � 주식 단위� 보통� 1주를 수령� 권리� 의미하며, 배당� 상응하는 단위� 원래 부여된 보상� 동일� 일정� 따라 베스트되� 지급됩니다.

Catherine Cusack, administratrice de Sabra Health Care REIT, Inc. (SBRA), s'est vu attribuer 877 unités supplémentaires d'actions ordinaires le 29/08/2025 en tant que paiements équivalents aux dividendes dans le cadre du Performance Incentive Plan 2009 de l'émetteur, sans coût en numéraire. À la suite de la transaction, elle détient au total, à titre bénéficiaire, 71 276 actions ou unités d'actions, comprenant 6 922 unités non acquises et 49 854 unités acquises avec paiement différé. Chaque unité d'action équivaut au droit de recevoir une action ordinaire et les unités équivalentes aux dividendes acquerront leurs droits et seront versées selon le même calendrier que les attributions initiales.

Catherine Cusack, Direktorin von Sabra Health Care REIT, Inc. (SBRA), erhielt am 29.08.2025 als dividendenäquivalente Zahlung im Rahmen des Performance Incentive Plan 2009 des Emittenten 877 zusätzliche Stammaktieneinheiten ohne Baraufwand. Nach der Transaktion besitzt sie wirtschaftlich insgesamt 71.276 Aktien oder Aktieneinheiten, darunter 6.922 nicht unverfallbare (unvested) Einheiten und 49.854 unverfallbare, mit aufgeschobener Auszahlung versehene Einheiten. Jede Aktieneinheit entspricht dem Recht auf den Erhalt einer Stammaktie, und die dividendenäquivalenten Einheiten werden nach dem gleichen Zeitplan wie die ursprünglichen Zuwendungen unverfallbar und ausgezahlt.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Cusack Catherine

(Last) (First) (Middle)
C/O SABRA HEALTH CARE REIT, INC.
1781 FLIGHT WAY

(Street)
TUSTIN CA 92782

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Sabra Health Care REIT, Inc. [ SBRA ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
08/29/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 08/29/2025 A 877(1) A $0 71,276(2) D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Represents stock units credited to the reporting person in the form of dividend equivalent payments on stock units previously granted to the reporting person that are outstanding under the Issuer's 2009 Performance Incentive Plan, calculated on the basis of the market value of the Issuer's common stock on the dividend payment date. These units will vest and become payable on the same terms as the original stock units to which they relate.
2. Includes 6,922 unvested stock units and 49,854 stock units that have vested but the payment of which has been deferred. Each stock unit represents the right to receive one share of the Issuer's Common Stock.
Remarks:
/s/ Michael Costa, as Attorney-in-Fact 09/03/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transaction did Catherine Cusack report on Form 4 for SBRA?

The Form 4 reports the acquisition of 877 common stock units on 08/29/2025 as dividend-equivalent payments under the 2009 Performance Incentive Plan.

How many total shares or units does the reporting person beneficially own after the transaction?

After the reported transaction the reporting person beneficially owns 71,276 shares or stock units in total.

How many of the reported units are unvested or deferred?

The filing discloses 6,922 unvested stock units and 49,854 vested units with payment deferred.

Was any cash paid for the 877 units reported on the Form 4?

No cash was paid; the units were credited as dividend equivalents and are reported with a price of $0.

Do the dividend-equivalent units have different vesting than the original awards?

No; the filing states these units "will vest and become payable on the same terms as the original stock units to which they relate."
Sabra Health Care Reit Inc

NASDAQ:SBRA

SBRA Rankings

SBRA Latest News

SBRA Latest SEC Filings

SBRA Stock Data

4.58B
236.75M
1.27%
101.31%
8.01%
REIT - Healthcare Facilities
AG˹ٷ Estate Investment Trusts
United States
TUSTIN